Published in BMC Evol Biol on March 07, 2013
GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence. Diabetologia (2014) 0.97
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2. Pharmacogenet Genomics (2014) 0.97
Structural and functional evolution of positively selected sites in pine glutathione S-transferase enzyme family. J Biol Chem (2013) 0.86
What does the nr5S DNA multigene family tell us about the genomic relationship between Dasypyrum breviaristatum and D. villosum (Triticeae: Poaceae)? Mol Genet Genomics (2014) 0.80
Structures and functions of insect arylalkylamine N-acetyltransferase (iaaNAT); a key enzyme for physiological and behavioral switch in arthropods. Front Physiol (2015) 0.78
Arylamine N-acetyl Transferase (NAT) in the blue secretion of Telescopium telescopium: xenobiotic metabolizing enzyme as a biomarker for detection of environmental pollution. Springerplus (2014) 0.75
Transcriptome Sequencing of Lima Bean (Phaseolus lunatus) to Identify Putative Positive Selection in Phaseolus and Legumes. Int J Mol Sci (2015) 0.75
Structure and evolution of the filaggrin gene repeated region in primates. BMC Evol Biol (2017) 0.75
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol (2003) 102.57
MODELTEST: testing the model of DNA substitution. Bioinformatics (1998) 101.19
PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol (2007) 45.68
PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci (1997) 45.07
Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res (1988) 32.89
A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol Biol Evol (1994) 19.91
Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics (2000) 14.84
Bayes empirical bayes inference of amino acid sites under positive selection. Mol Biol Evol (2005) 11.26
Analyzing the mosaic structure of genes. J Mol Evol (1992) 10.99
Statistical tests for detecting gene conversion. Mol Biol Evol (1989) 9.86
RDP3: a flexible and fast computer program for analyzing recombination. Bioinformatics (2010) 9.49
Evaluation of an improved branch-site likelihood method for detecting positive selection at the molecular level. Mol Biol Evol (2005) 8.74
Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution. Mol Biol Evol (1998) 8.74
PAL2NAL: robust conversion of protein sequence alignments into the corresponding codon alignments. Nucleic Acids Res (2006) 8.36
Codon-substitution models for detecting molecular adaptation at individual sites along specific lineages. Mol Biol Evol (2002) 7.21
RDP: detection of recombination amongst aligned sequences. Bioinformatics (2000) 6.83
Evaluation of methods for detecting recombination from DNA sequences: computer simulations. Proc Natl Acad Sci U S A (2001) 6.72
Concerted and birth-and-death evolution of multigene families. Annu Rev Genet (2005) 6.37
Sister-scanning: a Monte Carlo procedure for assessing signals in recombinant sequences. Bioinformatics (2000) 4.29
Accuracy and power of statistical methods for detecting adaptive evolution in protein coding sequences and for identifying positively selected sites. Genetics (2004) 4.22
A modified bootscan algorithm for automated identification of recombinant sequences and recombination breakpoints. AIDS Res Hum Retroviruses (2005) 4.21
Accuracy and power of the likelihood ratio test in detecting adaptive molecular evolution. Mol Biol Evol (2001) 4.03
Accuracy and power of bayes prediction of amino acid sites under positive selection. Mol Biol Evol (2002) 3.26
Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res (2002) 2.62
Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol (1990) 2.31
Statistical properties of the branch-site test of positive selection. Mol Biol Evol (2010) 1.85
A maximum likelihood method for detecting functional divergence at individual codon sites, with application to gene family evolution. J Mol Evol (2004) 1.70
Boundaries of gene conversion within the duplicated human alpha-globin genes. Concerted evolution by segmental recombination. J Biol Chem (1983) 1.69
Genomicus: a database and a browser to study gene synteny in modern and ancestral genomes. Bioinformatics (2010) 1.63
The UCSC Genome Browser. Curr Protoc Bioinformatics (2009) 1.59
Arylamine N-acetyltransferases: what we learn from genes and genomes. Drug Metab Rev (2005) 1.27
Rapid birth-death evolution specific to xenobiotic cytochrome P450 genes in vertebrates. PLoS Genet (2007) 1.26
Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J (2002) 1.24
N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine. Expert Opin Drug Metab Toxicol (2009) 1.24
Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. Am J Hum Genet (2006) 1.23
Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab (2008) 1.19
Worldwide distribution of NAT2 diversity: implications for NAT2 evolutionary history. BMC Genet (2008) 1.19
Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2. Carcinogenesis (2007) 1.17
Arylamine N-acetyltransferases: structural and functional implications of polymorphisms. Toxicology (2008) 1.15
Chromosomal localization of human genes for arylamine N-acetyltransferase. Biochem J (1994) 1.13
Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts. Birth Defects Res A Clin Mol Teratol (2004) 1.13
Arylamine N-acetyltransferases: from structure to function. Drug Metab Rev (2008) 1.12
Cytochrome P450 1 genes in early deuterostomes (tunicates and sea urchins) and vertebrates (chicken and frog): origin and diversification of the CYP1 gene family. Mol Biol Evol (2007) 1.12
A revised evolutionary history of the CYP1A subfamily: gene duplication, gene conversion, and positive selection. J Mol Evol (2006) 1.10
Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey. PLoS One (2011) 1.07
Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases. J Biol Chem (2007) 1.07
Sub-Saharan African coding sequence variation and haplotype diversity at the NAT2 gene. Hum Mutat (2006) 1.04
Arylamine N-acetyltransferases. Expert Opin Drug Metab Toxicol (2007) 1.04
Structure and mechanism of arylamine N-acetyltransferases. Curr Top Med Chem (2006) 1.03
Structure-function studies of human arylamine N-acetyltransferases NAT1 and NAT2. Functional analysis of recombinant NAT1/NAT2 chimeras expressed in Escherichia coli. J Biol Chem (1994) 1.02
Population genetic diversity of the NAT2 gene supports a role of acetylation in human adaptation to farming in Central Asia. Eur J Hum Genet (2007) 1.01
Multiple advantageous amino acid variants in the NAT2 gene in human populations. PLoS One (2008) 1.00
Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity. Pharmacogenomics J (2006) 1.00
Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos. Hum Mol Genet (2000) 0.99
Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism. Biochem Biophys Res Commun (2007) 0.98
Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours. Cytogenet Cell Genet (1997) 0.98
Risk of limb deficiency defects associated with NAT1, NAT2, GSTT1, GSTM1, and NOS3 genetic variants, maternal smoking, and vitamin supplement intake. Am J Med Genet A (2006) 0.97
Neutral and non-neutral evolution of duplicated genes with gene conversion. Genes (Basel) (2011) 0.95
An improved likelihood ratio test for detecting site-specific functional divergence among clades of protein-coding genes. Mol Biol Evol (2011) 0.95
Loss of function polymorphisms in NAT1 protect against spina bifida. Hum Genet (2006) 0.94
In silico sequence analysis of arylamine N-acetyltransferases: evidence for an absence of lateral gene transfer from bacteria to vertebrates and first description of paralogs in bacteria. Biochem Biophys Res Commun (2002) 0.92
Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function. Biochem Soc Trans (2003) 0.90
Gene conversion and functional divergence in the beta-globin gene family. J Mol Evol (2004) 0.90
Cytosolic arylamine N-acetyltransferase (NAT) deficiency in the dog and other canids due to an absence of NAT genes. Biochem Pharmacol (1997) 0.90
The NAT1 C1095A polymorphism, maternal multivitamin use and smoking, and the risk of spina bifida. Birth Defects Res A Clin Mol Teratol (2005) 0.89
Arylamine N-acetyltransferases in prokaryotic and eukaryotic genomes: a survey of public databases. Curr Drug Metab (2008) 0.88
Computational and experimental analyses of mammalian arylamine N-acetyltransferase structure and function. Drug Metab Dispos (2007) 0.87
Structural divergence and adaptive evolution in mammalian cytochromes P450 2C. Gene (2006) 0.87
Adaptive evolution of Toll-like receptor 5 in domesticated mammals. BMC Evol Biol (2012) 0.86
Comparative genomic and phylogenetic investigation of the xenobiotic metabolizing arylamine N-acetyltransferase enzyme family. FEBS Lett (2010) 0.86
CYP3 phylogenomics: evidence for positive selection of CYP3A4 and CYP3A7. Pharmacogenet Genomics (2008) 0.85
Influence of polymorphic N-acetyltransferases on non-malignant spontaneous disorders and on response to drugs. Curr Drug Metab (2008) 0.85
Human N-acetyltransferases and drug-induced hepatotoxicity. Curr Drug Metab (2008) 0.84
Characterization of genetic variation and natural selection at the arylamine N-acetyltransferase genes in global human populations. Pharmacogenomics (2011) 0.84
Molecular evolution and the role of oxidative stress in the expansion and functional diversification of cytosolic glutathione transferases. BMC Evol Biol (2010) 0.83
Update on the pharmacogenetics of NATs: structural considerations. Pharmacogenomics (2008) 0.82
Molecular evolution and functional divergence of the cytochrome P450 3 (CYP3) Family in Actinopterygii (ray-finned fish). PLoS One (2010) 0.81
Exon-specific gene correction (conversion) during short evolutionary periods: homogenization in a two-gene family encoding the beta-chain constant region of the T-lymphocyte antigen receptor. Mol Biol Evol (1992) 0.80
Insights into the phylogeny or arylamine N-acetyltransferases in fungi. J Mol Evol (2010) 0.80
Functional effects of genetic polymorphisms in the N-acetyltransferase 1 coding and 3' untranslated regions. Birth Defects Res A Clin Mol Teratol (2011) 0.79
Computational study of the three-dimensional structure of N-acetyltransferase 2-acetyl coenzyme a complex. Biol Pharm Bull (2010) 0.78
Prediction of sites under adaptive evolution in cytochrome P450 sequences and their relationship to substrate recognition sites. Pharmacogenet Genomics (2008) 0.77
Hantavirus in African wood mouse, Guinea. Emerg Infect Dis (2006) 2.49
Novel hantavirus sequences in Shrew, Guinea. Emerg Infect Dis (2007) 2.44
Revisiting Neandertal diversity with a 100,000 year old mtDNA sequence. Curr Biol (2006) 2.04
A predominantly neolithic origin for Y-chromosomal DNA variation in North Africa. Am J Hum Genet (2004) 2.02
Origin of strigolactones in the green lineage. New Phytol (2012) 1.78
Blindsnake evolutionary tree reveals long history on Gondwana. Biol Lett (2010) 1.53
Role of intraspecies recombination in the spread of pathogenicity islands within the Escherichia coli species. PLoS Pathog (2009) 1.35
EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib resistance and neoplastic transformation. Clin Cancer Res (2008) 1.30
Decreasing the effects of horizontal gene transfer on bacterial phylogeny: the Escherichia coli case study. Mol Phylogenet Evol (2004) 1.27
Assessing natural introgression in 2 biomedical model species, the rhesus macaque (Macaca mulatta) and the long-tailed macaque (Macaca fascicularis). J Hered (2008) 1.24
Worldwide distribution of NAT2 diversity: implications for NAT2 evolutionary history. BMC Genet (2008) 1.19
Mitochondrial DNA sequence phylogeny of 4 populations of the widely distributed cynomolgus macaque (Macaca fascicularis fascicularis). J Hered (2008) 1.17
Fluctuation of abundance and Lassa virus prevalence in Mastomys natalensis in Guinea, West Africa. Vector Borne Zoonotic Dis (2007) 1.14
Arylamine N-acetyltransferases: from structure to function. Drug Metab Rev (2008) 1.12
On the use of haplotype phylogeny to detect disease susceptibility loci. BMC Genet (2005) 1.10
Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey. PLoS One (2011) 1.07
Landscape genetics of an endangered lemur (Propithecus tattersalli) within its entire fragmented range. Mol Ecol (2010) 1.02
GM haplotype diversity of 82 populations over the world suggests a centrifugal model of human migrations. Am J Phys Anthropol (2004) 1.01
Genetic data suggest a natural prehuman origin of open habitats in northern Madagascar and question the deforestation narrative in this region. Proc Natl Acad Sci U S A (2012) 1.00
Clustering of haplotypes based on phylogeny: how good a strategy for association testing? Eur J Hum Genet (2006) 1.00
Very virulent infectious bursal disease virus: reduced pathogenicity in a rare natural segment-B-reassorted isolate. J Gen Virol (2006) 1.00
Selection-driven transcriptome polymorphism in Escherichia coli/Shigella species. Genome Res (2005) 1.00
Pinpointing a selective sweep to the chimpanzee MHC class I region by comparative genomics. Mol Ecol (2008) 0.99
The selective footprints of viral pressures at the human RIG-I-like receptor family. Hum Mol Genet (2011) 0.98
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2. Pharmacogenet Genomics (2014) 0.97
A DNA metabarcoding study of a primate dietary diversity and plasticity across its entire fragmented range. PLoS One (2013) 0.96
Arylamine N-acetyltransferases--from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention. Adv Pharmacol (2012) 0.96
Inferring haplotypes at the NAT2 locus: the computational approach. BMC Genet (2005) 0.93
Genomic plasticity of the immune-related Mhc class I B region in macaque species. BMC Genomics (2008) 0.91
Changes in consensus arylamine N-acetyltransferase gene nomenclature. Pharmacogenet Genomics (2008) 0.91
Molecular evidence for an Asian origin of monitor lizards followed by Tertiary dispersals to Africa and Australasia. Biol Lett (2012) 0.91
Human genetic differentiation across the Strait of Gibraltar. BMC Evol Biol (2010) 0.89
The evolutionary landscape of cytosolic microbial sensors in humans. Am J Hum Genet (2012) 0.88
Arylamine N-acetyltransferases in prokaryotic and eukaryotic genomes: a survey of public databases. Curr Drug Metab (2008) 0.88
The impact of human conflict on the genetics of Mastomys natalensis and Lassa virus in West Africa. PLoS One (2012) 0.87
Human neutral genetic variation and forensic STR data. PLoS One (2012) 0.87
Genetic structure of Mediterranean populations revealed by Y-chromosome haplotype analysis. Am J Phys Anthropol (2003) 0.87
Comparative genomic and phylogenetic investigation of the xenobiotic metabolizing arylamine N-acetyltransferase enzyme family. FEBS Lett (2010) 0.86
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. Clin Infect Dis (2013) 0.85
Compound evolutionary history of the rhesus macaque MHC class I B region revealed by microsatellite analysis and localization of retroviral sequences. PLoS One (2009) 0.84
Reproductive characteristics of Mastomys natalensis and Lassa virus prevalence in Guinea, West Africa. Vector Borne Zoonotic Dis (2008) 0.84
Taiwan Y-chromosomal DNA variation and its relationship with Island Southeast Asia. BMC Genet (2014) 0.83
Sex-specific selection on the human X chromosome? Genet Res (2004) 0.83
Evolutionary dynamics of duplicated microsatellites shared by sex chromosomes. J Mol Evol (2003) 0.82
Analysis of the French National Registry of unrelated bone marrow donors, using surnames as a tool for improving geographical localisation of HLA haplotypes. Eur J Hum Genet (2003) 0.82
aes, the gene encoding the esterase B in Escherichia coli, is a powerful phylogenetic marker of the species. BMC Microbiol (2009) 0.81
Local population structure in Arabian Peninsula revealed by Y-STR diversity. Hum Hered (2009) 0.81
A large panel of microsatellite markers for genetic studies in the infra-order catarrhini. Folia Primatol (Basel) (2009) 0.80
Genetic structure of Algerian populations. Am J Hum Biol (2006) 0.80
Spatial variation in density and total size estimates in fragmented primate populations: the golden-crowned sifaka (Propithecus tattersalli). Am J Primatol (2010) 0.80
High-throughput microtiter well-based chemiluminometric genotyping of 15 HBB gene mutations in a dry-reagent format. Clin Chem (2007) 0.79
SNP selection at the NAT2 locus for an accurate prediction of the acetylation phenotype. Genet Med (2006) 0.79
Data-mining methods as useful tools for predicting individual drug response: application to CYP2D6 data. Hum Hered (2006) 0.78
No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy. J Infect Dis (2011) 0.78
PharmGKB summary: isoniazid pathway, pharmacokinetics. Pharmacogenet Genomics (2016) 0.77
On the use of phylogeny-based tests to detect association between quantitative traits and haplotypes. Genet Epidemiol (2009) 0.77
Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model animal for endometriosis. Pharmacogenet Genomics (2007) 0.76
A highly polymorphic insertion in the Y-chromosome amelogenin gene can be used for evolutionary biology, population genetics and sexing in Cetacea and Artiodactyla. BMC Genet (2008) 0.75
Evaluating NAT2PRED for inferring the individual acetylation status from unphased genotype data. BMC Med Genet (2009) 0.75
A microarray system for Y chromosomal and mitochondrial single nucleotide polymorphism analysis in chimpanzee populations. Mol Ecol Resour (2008) 0.75
Selecting predictive markers for pharmacogenetic traits: tagging vs. data-mining approaches. Hum Hered (2008) 0.75